Monoclonal anti-glial fibrillary acid

The University of Nebraska Medical Center, a state institution operating under the Board of Regents of the University of Nebraska, awarded a purchase order to Sigma Aldrich Inc. for the procurement of laboratory reagents. The contract, issued on February 4, 2026, has a total value of $661 and covers delivery by February 11, 2026. The prime contractor, Sigma Aldrich Inc., is located in Chicago, Illinois, and will deliver the ordered materials to the Pharmacology & Experimental Neuroscience department at the University of Nebraska Medical Center in Omaha, Nebraska.

The specific deliverable under this purchase order is one unit of Monoclonal Anti-Glial Fibrillary Acid (material number G3893-.2ML) at a unit price of $661.00. This monoclonal antibody product is a specialized research reagent intended for use in the University's pharmacology and neuroscience research programs. The purchase order includes standard commercial terms of Net 30 payment and F.O.B. destination shipping, with vendor acceptance required within 10 days of order issuance and all shipments requiring packing slips bearing the purchase order number.